In contrast, a pro-tumorigenic role for SLFN5 has been suggested in glioblastoma, where it acts as a co-repressor with signal transducer and activator of transcription 1(STAT1) in interferon-mediated responses [18]. The gene discussed is STAT1; the disease is glioblastoma.